We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+13.33%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$2.12B
AUM Growth
+$254M
Cap. Flow
+$26.1M
Cap. Flow %
1.23%
Top 10 Hldgs %
66.02%
Holding
2,842
New
193
Increased
990
Reduced
833
Closed
259

Sector Composition

Rank Sector Weight
1 Technology 6.56%
2 Consumer Discretionary 4.39%
3 Financials 3.61%
4 Healthcare 3.17%
5 Consumer Staples 2.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOP icon
2501
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.59B
$1K ﹤0.01%
11
ZEPP
2502
Zepp Health
ZEPP
$64.8M
$1K ﹤0.01%
+21
New +$1.05K
BWIN
2503
Baldwin Insurance Group
BWIN
$2.6B
$1K ﹤0.01%
46
-11
-19% -$318
HA
2504
DELISTED
Hawaiian Holdings, Inc.
HA
$1K ﹤0.01%
+33
New +$559
CBD
2505
DELISTED
Companhia Brasileira de Distribuicao
CBD
$1K ﹤0.01%
100
-70
-41% -$895
KBNT
2506
DELISTED
Kubient, Inc. Common Stock
KBNT
$1K ﹤0.01%
+150
New +$620
ARGO
2507
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$1K ﹤0.01%
21
-14
-40% -$559
RETA
2508
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1K ﹤0.01%
9
-5
-36% -$657
DRTT
2509
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
$1K ﹤0.01%
500
ACGN
2510
DELISTED
Aceragen Inc
ACGN
$1K ﹤0.01%
11
FRG
2511
DELISTED
Franchise Group, Inc.
FRG
$1K ﹤0.01%
36
KBAL
2512
DELISTED
Kimball International
KBAL
$1K ﹤0.01%
46
CSII
2513
DELISTED
Cardiovascular Systems, Inc.
CSII
$1K ﹤0.01%
27
-11
-29% -$414
ATCX
2514
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$1K ﹤0.01%
+111
New +$788
ALBO
2515
DELISTED
Albireo Pharma Inc
ALBO
$1K ﹤0.01%
33
TCDA
2516
DELISTED
Tricida, Inc. Common Stock
TCDA
$1K ﹤0.01%
134
+31
+30% +$238
CLVS
2517
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
214
-405
-65% -$2.05K
EPZM
2518
DELISTED
Epizyme, Inc
EPZM
$1K ﹤0.01%
83
EPAY
2519
DELISTED
Bottomline Technologies Inc
EPAY
$1K ﹤0.01%
23
ARNA
2520
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1K ﹤0.01%
+8
New +$600
VCRA
2521
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1K ﹤0.01%
+28
New +$960
FMBI
2522
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$1K ﹤0.01%
+44
New +$605
ODT
2523
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$1K ﹤0.01%
+67
New +$1.03K
SNR
2524
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$1K ﹤0.01%
134
-173
-56% -$845
TBIO
2525
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$1K ﹤0.01%
53

Similar funds

SignatureFD's Q4 2020 Portfolio in Review

As of Q4 2020, SignatureFD held 2,842 positions worth $2.12B, up 14% from $1.87B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

SignatureFD's Q4 2020 filing shows 193 new, 990 increased, 833 reduced and 259 closed positions. Its largest new stake was AbbVie: 27,680 shares worth $2.97M. The largest sale was iShares Core S&P 500 ETF, an estimated $3.01M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 6.5% a quarter earlier, followed by Consumer Discretionary and Financials.

  • SignatureFD's largest Q4 2020 buy was AbbVie: 27,680 shares worth $2.97M.
  • SignatureFD added most to Vanguard Dividend Appreciation ETF in Q4 2020, an estimated $12.4M increase.
  • SignatureFD's biggest Q4 2020 reduction was iShares Core S&P 500 ETF, cutting an estimated $3.01M.
  • SignatureFD fully exited iShares Floating Rate Bond ETF in Q4 2020, selling an estimated $1.25M.
  • SignatureFD's ten largest holdings make up 66% of its $2.12B portfolio in Q4 2020.
  • SignatureFD opened 193 new positions and closed 259 in Q4 2020.
  • SignatureFD's portfolio value rose 14% quarter-over-quarter to $2.12B.

Based on SignatureFD's 13F filing for Q4 2020, filed 11 Feb 2021.